Abstract
Prostate cancer is the most common malignancy in men. For the development of potential anti-prostate cancer agents, a series of arylpiperazine derivatives was synthesized based on previous studies. The target compounds were synthesized via three-step reaction and their in vitro cytotoxic efficacies against a panel of three human prostate cancer cell lines (PC-3, LNCaP, and DU145) and one normal prostate epithelial cell line (WPMY-1) were evaluated by CCK-8 assay. The derivatives 6, 7, 8, 10, 11, 13, 16, 20, 21, 22 and 25 showed important cytotoxic actions against the individual tested cancer cell line with IC50 values <10 μM. The results showed that the o-substituted phenyl group derivatives and m-substituted phenyl group derivatives displayed improved cytotoxic activity against PC-3 cells.
Keywords: Synthesis, derivatives, prostate cancer, CCK-8 assay, cytotoxicity, structure-activity relationship.
Letters in Organic Chemistry
Title:Synthesis and Biological Evaluation of Arylpiperazine Derivatives as Anticancer Agents
Volume: 15 Issue: 11
Author(s): Hong Chen, Zonglin Yang, Tao Sun, Jiangxiu Niu, Xiumei Tian*Mu Yuan*
Affiliation:
- School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou,China
- Pharmaceutical Research Center, Guangzhou Medical University, Guangzhou,China
Keywords: Synthesis, derivatives, prostate cancer, CCK-8 assay, cytotoxicity, structure-activity relationship.
Abstract: Prostate cancer is the most common malignancy in men. For the development of potential anti-prostate cancer agents, a series of arylpiperazine derivatives was synthesized based on previous studies. The target compounds were synthesized via three-step reaction and their in vitro cytotoxic efficacies against a panel of three human prostate cancer cell lines (PC-3, LNCaP, and DU145) and one normal prostate epithelial cell line (WPMY-1) were evaluated by CCK-8 assay. The derivatives 6, 7, 8, 10, 11, 13, 16, 20, 21, 22 and 25 showed important cytotoxic actions against the individual tested cancer cell line with IC50 values <10 μM. The results showed that the o-substituted phenyl group derivatives and m-substituted phenyl group derivatives displayed improved cytotoxic activity against PC-3 cells.
Export Options
About this article
Cite this article as:
Chen Hong , Yang Zonglin , Sun Tao , Niu Jiangxiu , Tian Xiumei *, Yuan Mu *, Synthesis and Biological Evaluation of Arylpiperazine Derivatives as Anticancer Agents, Letters in Organic Chemistry 2018; 15 (11) . https://dx.doi.org/10.2174/1570178615666180518103641
DOI https://dx.doi.org/10.2174/1570178615666180518103641 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
PDGF/PDGFR Signaling and Targeting in Cancer Growth and Progression: Focus on Tumor Microenvironment and Cancer-associated Fibroblasts
Current Pharmaceutical Design Meet Our Editorial Board Member
Mini-Reviews in Medicinal Chemistry Mediterranean Food Pattern in Rheumatoid Arthritis
Current Rheumatology Reviews Recent Advances in Carbon Nanotubes as Delivery Systems for Anticancer Drugs
Current Medicinal Chemistry Cholinergic Receptors as Target for Cancer Therapy in a Systems Medicine Perspective
Current Molecular Medicine Prostate Cancer: Biology, Incidence, Detection Methods, Treatment Methods, and Vaccines
Current Topics in Medicinal Chemistry A Survey of Prostate Segmentation Techniques in Different Imaging Modalities
Current Medical Imaging Selenium Compounds Biotransformed by Mushrooms: Not Only Dietary Sources, But Also Toxicity Mediators
Current Nutrition & Food Science Protease-Activated Receptors (PARs) as Therapeutic Targets: Development of Agonists / Antagonists and Modulation of Gastrointestinal Functions
Drug Design Reviews - Online (Discontinued) Literature Review: Use of Family History for Primary Paediatric Care as the Next Step Towards use of Genomics in Healthcare
Current Pediatric Reviews Intracellular Delivery of Nanocarriers for Cancer Therapy
Current Nanoscience Inhibitors of HDACs - Effective Drugs Against Cancer?
Current Cancer Drug Targets Therapeutic Vaccines Explored in Patients with Non-Small Cell Lung Cancer
Anti-Cancer Agents in Medicinal Chemistry Systemic Delivery and Quantification of Unformulated Interfering RNAs In Vivo
Current Topics in Medicinal Chemistry The IGF-I/IGF-I Receptor Pathway: Implications in the Pathophysiology of Thyroid Cancer
Current Medicinal Chemistry An Overview on Global Trends in Nanotechnological Approaches for Alzheimer Therapy
Current Drug Metabolism Cancer Preventive Effects of Vitamin E
Current Pharmaceutical Biotechnology Iron Chelators: Development of Novel Compounds with High and Selective Anti-Tumour Activity
Current Drug Delivery An Overview of Phytochemical and Pharmacological Profile of <i>Morus alba</i> Linn
Current Bioactive Compounds The Place of the Bioisosteric Sila-Substitution in Drug Design
Drug Design Reviews - Online (Discontinued)